Monroe Biomedical Research

Monroe Biomedical Research (MBR) is a multi-specialty clinical research organization operating fully owned research sites. MBR excels in Phase 1-4 cardiometabolic, endocrinology, and respiratory clinical trials, as well as general medicine studies for drugs, medical devices, and diagnostics. Sponsors and CROs partner with MBR for: • Therapeutic excellence: Distinguished investigators and clinical staff with deep experience in specific disease areas and reaching specialty populations. • Reliable execution: Centrally managed multi-site operations to accelerate timelines from startup through closeout, especially for high-volume trials. • Phase 1 capabilities: Specialized facilities for complex early-phase work. • Recruitment and retention expertise: Expert-led programs designed to consistently outperform industry benchmarks. By conducting research with both scientific rigor and genuine respect for the people who make it possible, MBR provides better experiences for everyone involved — from participants to partners. Whether you are a Sponsor evaluating new site partnerships, a CRO building a select network of high-performing sites, or a professional looking to do meaningful work in clinical research, connect with MBR. Learn more at MonroeResearch.com